Skip to Content

BMS 150 mg 3624 (Reyataz 150 mg)

Generic Name: atazanavir

Pill with imprint BMS 150 mg 3624 is Blue, Capsule-shape and has been identified as Reyataz 150 mg. It is supplied by Bristol-Myers Squibb.

Reyataz is used in the treatment of hiv infection; nonoccupational exposure and belongs to the drug class protease inhibitors. There is no proven risk in humans during pregnancy. Reyataz 150 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for BMS 150 mg 3624

Reyataz 150 mg BMS 150 mg 3624
Reyataz 150 mg BMS 150 mg 3624
Reyataz 150 mg BMS 150 mg 3624 Front
Reyataz 150 mg BMS 150 mg 3624 Back
Reyataz 150 mg BMS 150 mg 3624

Reyataz

Generic Name:
atazanavir
Imprint:
BMS 150 mg 3624
Strength:
150 mg
Color:
Blue
Size:
19.00 mm
Shape:
Capsule-shape
Availability:
Prescription only
Drug Class:
Protease inhibitors
Pregnancy Category:
B - No proven risk in humans
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Bristol-Myers Squibb
Inactive Ingredients:
crospovidone
lactose monohydrate
magnesium stearate
gelatin
FD&C Blue No. 2
titanium dioxide
ferric oxide red
ferric oxide yellow
isopropyl alcohol
ammonia
propylene glycol
butyl alcohol
alcohol
ferrosoferric oxide
shellac
Note: Inactive ingredients may vary.

Other Labelers / Repackagers:

NDC CodeLabeler / Repackager
35356-0068 Lake Erie Medical and Surgical Supply (repackager)

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide